Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 9569113
[patent_doc_number] => 20140186826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA'
[patent_app_type] => utility
[patent_app_number] => 13/917041
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11965
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917041
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917041 | METHOD OF JUDGING RISK FOR ONSET OF DRUG-INDUCED GRANULOCYTOPENIA | Jun 12, 2013 | Abandoned |
13/993745 | METHOD OF DETECTING RESISTANCE TO CANCER THERAPY | Jun 12, 2013 | Abandoned |
Array
(
[id] => 9147840
[patent_doc_number] => 20130302363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'DETECTION OF MAGE-A EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/917108
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23667
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917108
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917108 | DETECTION OF MAGE-A EXPRESSION | Jun 12, 2013 | Abandoned |
Array
(
[id] => 13289613
[patent_doc_number] => 10155987
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-18
[patent_title] => Methods of predicting resistance to JAK inhibitor therapy
[patent_app_type] => utility
[patent_app_number] => 13/916169
[patent_app_country] => US
[patent_app_date] => 2013-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15930
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916169
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916169 | Methods of predicting resistance to JAK inhibitor therapy | Jun 11, 2013 | Issued |
Array
(
[id] => 10407016
[patent_doc_number] => 20150292025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'METHYLATION BIOMARKERS FOR PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/408238
[patent_app_country] => US
[patent_app_date] => 2013-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5392
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408238
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408238 | Methylation biomarkers for prostate cancer | Jun 10, 2013 | Issued |
Array
(
[id] => 10414786
[patent_doc_number] => 20150299795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'CANCER-ASSOCIATED GERM-LINE AND SOMATIC MARKERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/404059
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23990
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404059
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404059 | CANCER-ASSOCIATED GERM-LINE AND SOMATIC MARKERS AND USES THEREOF | May 29, 2013 | Abandoned |
13/905109 | METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITIS | May 28, 2013 | Abandoned |
Array
(
[id] => 11881034
[patent_doc_number] => 09752195
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-05
[patent_title] => 'TTC8 as prognostic gene for progressive retinal atrophy in dogs'
[patent_app_type] => utility
[patent_app_number] => 14/404291
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12541
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404291
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404291 | TTC8 as prognostic gene for progressive retinal atrophy in dogs | May 23, 2013 | Issued |
Array
(
[id] => 9363097
[patent_doc_number] => 20140072970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'LAFORA\'S DISEASE GENE'
[patent_app_type] => utility
[patent_app_number] => 13/902291
[patent_app_country] => US
[patent_app_date] => 2013-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20199
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902291
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/902291 | Lafora's disease gene | May 23, 2013 | Issued |
Array
(
[id] => 9174360
[patent_doc_number] => 20130316345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Method of Determining the Genotype Relating to Hereditary Nasal Parakeratosis (HNPK) and Nucleic Acids Usable in Said Method'
[patent_app_type] => utility
[patent_app_number] => 13/899122
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3695
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/899122 | Method of determining the genotype relating to hereditary nasal parakeratosis (HNPK) and nucleic acids usable in said method | May 20, 2013 | Issued |
Array
(
[id] => 11663847
[patent_doc_number] => 20170152566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/889694
[patent_app_country] => US
[patent_app_date] => 2013-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 73048
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889694
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/889694 | GENE SEQUENCE VARIANCES IN GENES RELATED TO FOLATE METABOLISM HAVING UTILITY IN DETERMINING THE TREATMENT OF DISEASE | May 7, 2013 | Abandoned |
Array
(
[id] => 10499841
[patent_doc_number] => 09228237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Cystic fibrosis gene mutations'
[patent_app_type] => utility
[patent_app_number] => 13/872479
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 13654
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872479 | Cystic fibrosis gene mutations | Apr 28, 2013 | Issued |
Array
(
[id] => 9537604
[patent_doc_number] => 20140162252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'Composition for diagnosing Alzheimer\'s disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer\'s disease using the same'
[patent_app_type] => utility
[patent_app_number] => 13/870226
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4889
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870226
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870226 | Composition for diagnosing Alzheimer's disease using methylation status of HMOX1 gene and method for diagnosing Alzheimer's disease using the same | Apr 24, 2013 | Issued |
Array
(
[id] => 9263148
[patent_doc_number] => 20130345077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'DIAGNOSIS OF LYMPH NODE INVOLVEMENT IN RECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/864589
[patent_app_country] => US
[patent_app_date] => 2013-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13554
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13864589
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/864589 | DIAGNOSIS OF LYMPH NODE INVOLVEMENT IN RECTAL CANCER | Apr 16, 2013 | Abandoned |
Array
(
[id] => 9875013
[patent_doc_number] => 08962280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Methods for detecting DNA orginating from different individuals'
[patent_app_type] => utility
[patent_app_number] => 13/855974
[patent_app_country] => US
[patent_app_date] => 2013-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7864
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855974
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/855974 | Methods for detecting DNA orginating from different individuals | Apr 2, 2013 | Issued |
Array
(
[id] => 13637099
[patent_doc_number] => 09845506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Method for determining prognosis of prostate cancer in a subject
[patent_app_type] => utility
[patent_app_number] => 14/386292
[patent_app_country] => US
[patent_app_date] => 2013-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 13998
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386292
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/386292 | Method for determining prognosis of prostate cancer in a subject | Mar 18, 2013 | Issued |
Array
(
[id] => 9656684
[patent_doc_number] => 20140227690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'METHODS AND COMPOSITIONS FOR ASSESSMENT OF FETAL LUNG MATURITY'
[patent_app_type] => utility
[patent_app_number] => 13/838592
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19983
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838592
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838592 | METHODS AND COMPOSITIONS FOR ASSESSMENT OF FETAL LUNG MATURITY | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9671742
[patent_doc_number] => 20140235605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/833905
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61372
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/833905 | GENETIC POLYMORPHISMS ASSOCIATED WITH STATIN RESPONSE AND CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9042255
[patent_doc_number] => 20130244894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'NUCLEIC ACID-BASED AUTHENTICATION CODES'
[patent_app_type] => utility
[patent_app_number] => 13/796054
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15791
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13796054
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/796054 | NUCLEIC ACID-BASED AUTHENTICATION CODES | Mar 11, 2013 | Abandoned |
Array
(
[id] => 9895901
[patent_doc_number] => 20150051100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'DNA HYPERMETHYLATION OF PROMOTERS OF TARGET GENES AND CLINICAL DIAGNOSIS AND TREATMENT OF HPV RELATED DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/381604
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11912
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381604
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/381604 | DNA HYPERMETHYLATION OF PROMOTERS OF TARGET GENES AND CLINICAL DIAGNOSIS AND TREATMENT OF HPV RELATED DISEASE | Feb 26, 2013 | Abandoned |